Arbutus Biopharma (ABUS) Preferred Shares (2017 - 2021)

Arbutus Biopharma's Preferred Shares history runs 5 years deep, the most recent figure standing at $161.0 million for Q3 2021.

• In Q3 2021, Preferred Shares rose 10.04% year-over-year to $161.0 million; the TTM figure through Sep 2021 stood at $161.0 million (up 10.04% YoY), while the FY2020 annual figure was $149.4 million, up 8.83% from the prior year.
• Preferred Shares came in at $161.0 million for Q3 2021 at Arbutus Biopharma, up from $155.9 million in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $161.0 million in Q3 2021 to a low of $49.8 million in Q4 2017.
• A 5-year average of $132.5 million and a median of $135.8 million in 2019 frame the typical range for Preferred Shares.
• Across the five-year window, Preferred Shares surged 153.39% in 2018 and climbed 8.81% in 2021, its largest moves.
• Arbutus Biopharma's Preferred Shares stood at $49.8 million in 2017, then soared by 153.39% to $126.1 million in 2018, then rose by 8.84% to $137.3 million in 2019, then rose by 8.83% to $149.4 million in 2020, then gained by 7.74% to $161.0 million in 2021.
• According to Business Quant data, Preferred Shares over the past three periods registered $161.0 million, $155.9 million, and $152.6 million for Q3 2021, Q2 2021, and Q1 2021 respectively.

Peer Comparison